GJD2 and type 1 diabetes mellitus: These results are in contrast to our in vitro studies, as well as a previous study that used glibenclamide to increase Cx36 gap junction coupling and observed protection against T1D onset in the NOD mouse (Lamprianou, Gysemans et al., 2016).